Treatment of Early Aggressive Rheumatoid Arthritis (TEAR)

NCT00259610 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

755

Enrollment

OTHER

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: methotrexate
DRUG: sulfasalazine
DRUG: hydroxychloroquine
DRUG: etanercept

Sponsor

University of Alabama at Birmingham

Collaborators

[object Object]
[object Object]
[object Object]